We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

This study has been terminated.
(Slow accrual rate)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00981799
First Posted: September 22, 2009
Last Update Posted: November 24, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
GlaxoSmithKline
Novartis
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: No date given
  Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)